Search

everythinglearnresearchcommunity

for

Search:↓

Activating PPAR-γ signalling can protect hair follicle stem cells from damage caused by chemotherapy.

TICE salvage chemotherapy is effective for treating germ-cell tumors with poor prognosis.

Deuruxolitinib is FDA-approved for treating severe alopecia areata.

Radiation therapy successfully treated an elderly man's skin cancer and pre-cancerous scalp lesions.

Radiation therapy successfully treated an elderly man's skin cancer and pre-cancerous scalp lesions.

Biorregulatory therapy significantly improved the dog's health, reversing previous issues and eliminating the need for ongoing medication.

The dog recovered well from skin cancer and intestinal blockage after treatment.

A man developed alopecia areata after starting cancer treatment with vandetanib.

An emollient PLUS balm with ADE-G1 significantly improved skin dryness and quality of life in cancer patients with xerosis.

Docetaxel often causes hair loss, with limited effective treatments and no cure for permanent hair loss.

XEDAR triggers a specific signaling pathway in cells.

Blocking specific proteins can help remove aging cells and might treat age-related diseases and promote hair growth.

A cancer drug caused unusual hair growth on a 100-year-old man's scalp and eyelashes.

Exercise may help reduce treatment side effects and improve survival in metastatic colorectal cancer.

Palliative chemotherapy is cost-effective for advanced gastric and colorectal cancer but not clearly for pancreatic-biliary cancer.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

Mefloquine, an antimalarial drug, is effective in killing melanoma cells resistant to other treatments by causing lethal stress in the cells.

An elderly woman's upper lip lump, thought to be a mucocele, was actually a rare type of lymphoma usually found on legs, treated successfully with chemotherapy and radiation.

Antizyme slows skin tumor growth by reducing cell growth in mice.

Gefitinib and Sasam-Kyeongokgo together significantly reduce cancer growth and improve immune response in mice.

Perhexiline can effectively target ovarian cancer cells left after treatment.

Certain cancer drugs are strongly linked to nerve damage, requiring close monitoring and early treatment.

Deuruxolitinib significantly improves hair satisfaction in severe alopecia areata patients.

Erlotinib can cause significant but temporary hair loss in lung cancer patients.

Ruxolitinib helped regrow hair in a woman with a blood disorder and complete hair loss.

Chrysin makes docetaxel more effective and reduces its side effects in lung cancer treatment.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

Some breast cancer patients treated with high-dose docetaxel may experience permanent hair loss.

Chemoprevention can significantly lower cancer risks and needs more research and collaboration.